This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Pericleous, C Articles by Rahman, A PubMed PubMed Citation Articles by Pericleous, C Articles by Rahman, A Social Bookmarking                         What's this?

Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?

Medical Molecular Biology Unit, Institute of Child Health, University College London, London WC1N 1EH, UK; Centre for Rheumatology Research, Division of Medicine, University College London, London W1T 4JF, UK

I Giles

Medical Molecular Biology Unit, Institute of Child Health, University College London, London WC1N 1EH, UK; Centre for Rheumatology Research, Division of Medicine, University College London, London W1T 4JF, UK

A Rahman

Medical Molecular Biology Unit, Institute of Child Health, University College London, London WC1N 1EH, UK; Centre for Rheumatology Research, Division of Medicine, University College London, London W1T 4JF, UKAnisur.Rahman{at}ucl.ac.uk

Vascular dysfunction is key to the development of thrombosis in the antiphospholipid syndrome. This has been largely demonstrated by the upregulation of various cell surface and intracellular signalling molecules, as well as proinflammatory cytokine release from activated endothelial cells. Endothelial microparticles (EMP) are a further marker of endothelial activation but have been less extensively studied. We summarise evidence suggesting that these microparticles may be critical effectors of thrombosis in the antiphospholipid syndrome. There is evidence that levels of EMP are raised in patients with circulating antiphospholipid antibodies and that these EMP may be prothrombotic. The balance between markers of endothelial dysfunction (including EMP and circulating endothelial cells) and markers of repair such as circulating endothelial progenitor cells may be abnormal in patients with APS but this has not been proved and requires further study.

Lupus, Vol. 18, No. 8, 671-675 (2009)
DOI: 10.1177/0961203309103062


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?